Innovative Wound Care Solutions AVITA Medical's flagship RECELL® System offers a unique, FDA-approved therapy that accelerates wound healing using a patient’s own skin cells, positioning the company as a leader in advanced regenerative wound care and creating strong sales opportunities in hospitals and burn centers.

Recent Funding Boost With a recent $23 million equity financing, AVITA Medical is well-positioned to scale commercialization efforts, expand into new markets, and invest in sales strategies targeting trauma and burn treatment facilities globally.

Award-Winning Technology Recognition at the MedTech Breakthrough Awards and presentations at industry events highlight AVITA’s innovative platform, increasing credibility and appeal among healthcare providers and decision-makers looking for proven, award-winning solutions.

Market Engagement and Visibility Active participation in industry conferences, including the British Burn Association Annual Meeting and Acute Wound Care Showcases, presents opportunities for direct engagement with clinical decision-makers and potential key accounts seeking innovative solutions.

Strategic Product Expansion Beyond RECELL, AVITA’s portfolio includes collagen-based dermal matrices and biosynthetic wound matrices, offering cross-selling potential to hospitals and wound care clinics aiming to adopt comprehensive wound management therapies.